These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 18799993

  • 21. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G, Keyes LE, Maakestad KM, Olson S, Tissot van Patot MC, Hackett PH.
    Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
    [Abstract] [Full Text] [Related]

  • 22. Low-dose theophylline reduces symptoms of acute mountain sickness.
    Küpper TE, Strohl KP, Hoefer M, Gieseler U, Netzer CM, Netzer NC.
    J Travel Med; 2008; 15(5):307-14. PubMed ID: 19006503
    [Abstract] [Full Text] [Related]

  • 23. Acute mountain sickness in travelers who consulted a pre-travel clinic.
    Croughs M, Van Gompel A, Van den Ende J.
    J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098
    [Abstract] [Full Text] [Related]

  • 24. Hyperventilatory capacity--a predictor of altitude sickness.
    Hayat A, Hussain MM, Aziz S, Siddiqui AH, Hussain T.
    J Ayub Med Coll Abbottabad; 2006; 18(2):17-20. PubMed ID: 16977807
    [Abstract] [Full Text] [Related]

  • 25. Are the laboratory and field conditions observations of acute mountain sickness related?
    Savourey G, Guinet A, Besnard Y, Garcia N, Hanniquet A, Bittel J.
    Aviat Space Environ Med; 1997 Oct; 68(10):895-9. PubMed ID: 9327114
    [Abstract] [Full Text] [Related]

  • 26. Statistical models of acute mountain sickness.
    Vann RD, Pollock NW, Pieper CF, Murdoch DR, Muza SR, Natoli MJ, Wang LY.
    High Alt Med Biol; 2005 Oct; 6(1):32-42. PubMed ID: 15772498
    [Abstract] [Full Text] [Related]

  • 27. Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness.
    Meyer J.
    High Alt Med Biol; 2012 Dec; 13(4):281-4. PubMed ID: 23270446
    [Abstract] [Full Text] [Related]

  • 28. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA, Flores A, Serra J, Esnaola C, Barriento C.
    Wilderness Environ Med; 2007 Dec; 18(4):251-7. PubMed ID: 18076292
    [Abstract] [Full Text] [Related]

  • 29. Incidence of acute mountain sickness in adolescents.
    Dallimore J, Rowbotham EC.
    Wilderness Environ Med; 2009 Dec; 20(3):221-4. PubMed ID: 19737028
    [Abstract] [Full Text] [Related]

  • 30. Acute mountain sickness in children and their parents after rapid ascent to 3500 m (Putre, Chile).
    Moraga FA, Pedreros CP, Rodríguez CE.
    Wilderness Environ Med; 2008 Dec; 19(4):287-92. PubMed ID: 19099320
    [Abstract] [Full Text] [Related]

  • 31. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters.
    Bloch J, Duplain H, Rimoldi SF, Stuber T, Kriemler S, Allemann Y, Sartori C, Scherrer U.
    Pediatrics; 2009 Jan; 123(1):1-5. PubMed ID: 19117853
    [Abstract] [Full Text] [Related]

  • 32. Impact of Sleeping Altitude on Symptoms of Acute Mountain Sickness on Mt. Fuji.
    Horiuchi M, Uno T, Endo J, Handa Y, Hasegawa T.
    High Alt Med Biol; 2018 Jun; 19(2):193-200. PubMed ID: 29741971
    [Abstract] [Full Text] [Related]

  • 33. Incidence of acute mountain sickness in UK Military Personnel on Mount Kenya.
    Hazlerigg A, Woods DR, Mellor AJ.
    J R Army Med Corps; 2016 Dec; 162(6):465-469. PubMed ID: 26604255
    [Abstract] [Full Text] [Related]

  • 34. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN, Schalick LM, Delaney PA, Bernhard TM, Barnas GM.
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [Abstract] [Full Text] [Related]

  • 35. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
    Jafarian S, Gorouhi F, Salimi S, Lotfi J.
    Ann Neurol; 2007 Sep; 62(3):273-7. PubMed ID: 17557349
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the Lake Louise acute mountain sickness scoring system in a hypobaric chamber.
    Savourey G, Guinet A, Besnard Y, Garcia N, Hanniquet AM, Bittel J.
    Aviat Space Environ Med; 1995 Oct; 66(10):963-7. PubMed ID: 8526833
    [Abstract] [Full Text] [Related]

  • 37. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m).
    Pesce C, Leal C, Pinto H, González G, Maggiorini M, Schneider M, Bärtsch P.
    High Alt Med Biol; 2005 Oct; 6(2):158-66. PubMed ID: 16060850
    [Abstract] [Full Text] [Related]

  • 38. A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness.
    Bailey DM, Davies B, Young IS, Hullin DA, Seddon PS.
    Aviat Space Environ Med; 2001 Jun; 72(6):513-21. PubMed ID: 11396556
    [Abstract] [Full Text] [Related]

  • 39. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L, Sherpa C, Nickol A, Windsor J.
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [Abstract] [Full Text] [Related]

  • 40. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
    McDevitt M, McIntosh SE, Rodway G, Peelay J, Adams DL, Kayser B.
    Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.